Optimising Outcomes in Chronic Myeloid Leukaemia Through Rational Drug Selection Using Predictive Assay Results and Maximising Treatment Free Remissions [ 2018 - 2021 ]

Research Grant

[Cite as]

Researchers: Dr David Yeung (Principal investigator)

Brief description Although outcomes in chronic myeloid leukaemia are generally excellent, a number of important questions remain. In this grant, we propose to i) personalise the selection of frontline treatment for newly diagnosed patients, using biomarkers which can predict treatment response; ii) improve the probability of cure in patients aiming to stop their treatment, and iii) use ultra-sensitive molecular tests for disease detection to predict risk of disease relapse.

Funding Amount $AUD 193,596.68

Funding Scheme Early Career Fellowships

Notes Health Professional Research ECF

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]